选择语言

LYPD3

LYPD3信息

英文名称:Ly6/PLAUR domain-containing protein 3上市药物数量0
中文名称LY6/PLAUR结构域蛋白-3临床药物数量1
靶点别称C4.4A,GPI-Anchored Metastasis-Associated Protein Homolog,2310061G07Rik,GPI-Anchored Metastasis-Associated Protein C4.4A Homolog,MIG-C4,UNQ491/PRO1007,Ly6/PLAUR domain-containing protein 3,LYPD3,Matrigel-Induced Gene C4 Protein,LY6/PLAUR Domain Containing 3最高研发阶段临床一期
英文名称:Ly6/PLAUR domain-containing protein 3
中文名称LY6/PLAUR结构域蛋白-3
靶点别称C4.4A,GPI-Anchored Metastasis-Associated Protein Homolog,2310061G07Rik,GPI-Anchored Metastasis-Associated Protein C4.4A Homolog,MIG-C4,UNQ491/PRO1007,Ly6/PLAUR domain-containing protein 3,LYPD3,Matrigel-Induced Gene C4 Protein,LY6/PLAUR Domain Containing 3
上市药物数量0
临床药物数量1
最高研发阶段Phase 1 Clinical

LYPD3产品列表

  • 属性

    Protein (1)

  • 产品库

    在线 (1)

  • 物种

    Human (1)

  • 标签

    His Tag (1)

  • 标记

    Unconjugated (1)

共 1 项数据
  • 1

LYPD3分子背景

Ly6/PLAUR domain-containing protein 3 (LYPD3) is also known as MIG-C4 ,C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog and Matrigel-induced gene C4 protein,which is a cell membrane protein containing two UPAR/Ly6 domains. LYPD3 is expressed in placenta, skin and urothelium. LYPD3 is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. LYPD3 play a role in supporting cell migration and it is not only probably involved in urothelial cell-matrix interactions, but also in tumor progression.

LYPD3分子别名

LYPD3,MIG-C4,C4.4A

产品评论

  • pp*****asieris.cn 2024-08-08
    0人点赞
    公司在做ADC项目,需要评估动物实验PK与药效关系,用本抗体进行ELISA实验定量不同时间ADC的血浆浓度。抗体特异、灵敏、实验非常成功。
  • 分子信息
  • 产品列表